Loss of HLA class I expression in prostate cancer: Implications for immunotherapy

Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical Staging

1974 • 2,200 citations

Identification of human cancers deficient in antigen processing.

1993 • 625 citations

Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells

1983 • 586 citations

Natural history of HLA expression during tumour development

1993 • 448 citations

THE DETAILED DISTRIBUTION OF HLA-A, B, C ANTIGENS IN NORMAL HUMAN ORGANS

1984 • 410 citations

Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.

1994 • 333 citations

Changes in prostate cancer incidence and treatment in USA

1994 • 255 citations

Identification of ampoules.

1973 • 241 citations

Molecular Characterization of Defective Antigen Processing in Human Prostate Cancer

1995 • 240 citations

Demonstration of a Rational Strategy for Human Prostate Cancer Gene Therapy

1994 • 210 citations

Loss of MHC class‐I expression in cervical carcinomas

1990 • 184 citations

Immunotherapy of prostate cancer in the Dunning rat model: use of cytokine gene modified tumor vaccines.

1994 • 181 citations

Distribution of human Class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin.

1984 • 168 citations

Selective changes in expression of HLA class I polymorphic determinants in human solid tumors.

1989 • 150 citations

Loss of HLA‐A,B,C and de novo expression of HLA‐D in colorectal cancer

1986 • 136 citations

The influence of major histocompatibility complex class I antigens on tumor growth and metastasis

1987 • 80 citations

The role of surface HLA-A,B,C molecules in tumour immunity.

1992 • 60 citations

The biological consequences of altered MHC expression on tumours

1987 • 55 citations

Interleukin‐2 transfected prostate cancer cells generate a local antitumor effect in vivo

1994 • 45 citations

Modulated expression of human leucocyte antigen class I and class II determinants in hyperplastics and malignant human prostatic epithelium

1994 • 40 citations

Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.

1988 • 39 citations

HLA Expression by Benign and Malignant Prostatic Epithelium: Augmentation by Interferon-Gamma

1993 • 20 citations

Molecular and cellular markers for metastatic prostate cancer

1993 • 19 citations